Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
C4 Therapeutics, Inc. roi for the quarter ending 2023-12-31 was -53.83%, a change of -11.21% year-over-year.
C4 Therapeutics, Inc. roi for the quarter ending 2023-09-30 was -62.46%, a change of -30.09% year-over-year.
C4 Therapeutics, Inc. roi for the quarter ending 2023-06-30 was -57.30%, a change of -29.37% year-over-year.
C4 Therapeutics, Inc. roi for the quarter ending 2023-03-31 was -48.04%, a change of -22.86% year-over-year.
C4 Therapeutics, Inc. roi for fiscal 2023 was -53.83%, a change of -11.21% from fiscal 2022.
C4 Therapeutics, Inc. roi for fiscal 2022 was -42.62%, a change of -21.67% from fiscal 2021.
C4 Therapeutics, Inc. roi for fiscal 2021 was -20.95%.